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Abstract 
The zebrafish is a powerful model to explore the molecular genetics and expression of the vertebrate 
genome. The gene break transposon (GBT) is a unique insertional mutagen that reports the expression of 
the tagged member of the proteome while generating Cre-revertible genetic alleles. This 1000+ locus 
collection represents novel codex expression data from the illuminated mRFP protein trap, with 36% and 
87% of the cloned lines showcasing to our knowledge the first described expression of these genes at day 
2 and day 4 of development, respectively. Analyses of 183 molecularly characterized loci indicate a rich 
mix of genes involved in diverse cellular processes from cell signaling to DNA repair. The mutagenicity of 
the GBT cassette is very high as assessed using both forward and reverse genetic approaches. Sampling 
over 150 lines for visible phenotypes after 5dpf shows a similar rate of discovery of embryonic 
phenotypes as ENU and retroviral mutagenesis. Furthermore, five cloned insertions were in loci with 
previously described phenotypes; embryos homozygous for each of the corresponding GBT alleles 
displayed strong loss of function phenotypes comparable to published mutants using other mutagenesis 
strategies (ryr1b, fras1, tnnt2a, edar and hmcn1). Using molecular assessment after positional cloning, to 
date nearly all alleles cause at least a 99+% knockdown of the tagged gene. Interestingly, over 35% of the 
cloned loci represent 68 mutants in zebrafish orthologs of human disease loci, including nervous, 
cardiovascular, endocrine, digestive, musculoskeletal, immune and integument systems. The GBT protein 
trapping system enabled the construction of a comprehensive protein codex including novel expression 
annotation, identifying new functional roles of the vertebrate genome and generating a diverse collection 
of potential models of human disease. 
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Abstract 1 
 2 
The zebrafish is a powerful model to explore the molecular genetics and expression of the vertebrate 3 
genome. The gene break transposon (GBT) is a unique insertional mutagen that reports the expression of 4 
the tagged member of the proteome while generating Cre-revertible genetic alleles. This 1000+ locus 5 
collection represents novel codex expression data from the illuminated mRFP protein trap, with 36% 6 
and 87% of the cloned lines showcasing to our knowledge the first described expression of these genes 7 
at day 2 and day 4 of development, respectively. Analyses of 183 molecularly characterized loci indicate 8 
a rich mix of genes involved in diverse cellular processes from cell signaling to DNA repair. The 9 
mutagenicity of the GBT cassette is very high as assessed using both forward and reverse genetic 10 
approaches. Sampling over 150 lines for visible phenotypes after 5dpf shows a similar rate of discovery 11 
of embryonic phenotypes as ENU and retroviral mutagenesis. Furthermore, five cloned insertions were 12 
in loci with previously described phenotypes; embryos homozygous  for each of the corresponding GBT 13 
alleles displayed strong loss of function phenotypes comparable to published mutants using other 14 
mutagenesis strategies (ryr1b, fras1, tnnt2a, edar and hmcn1). Using molecular assessment after 15 
positional cloning, to date nearly all alleles cause at least a 99+% knockdown of the tagged gene. 16 
Interestingly, over 35% of the cloned loci represent 68 mutants in zebrafish orthologs of human disease 17 
loci, including nervous, cardiovascular, endocrine, digestive, musculoskeletal, immune and integument 18 
systems. The GBT protein trapping system enabled the construction of a comprehensive protein codex 19 
including novel expression annotation, identifying new functional roles of the vertebrate genome and 20 
generating a diverse collection of potential models of human disease. 21 
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Introduction 1 
With the generation of more than 100 sequenced vertebrate genomes (Meadows & Lindblad-Toh, 2017), 2 
the current key question is how to determine the role(s) of uncharacterized gene products in specific 3 
biological and pathological processes. For example, genes associated with human disease are being 4 
discovered at a rapid rate. However, the biological functions underlying this linkage is often unclear 5 
(Kettleborough et al., 2013). Model system science using loss of function approaches has been essential 6 
to the annotation of the genome to date including the discovery of novel processes and the biological 7 
mechanisms underlying disease (Stoeger, Gerlach, Morimoto, & Nunes Amaral, 2018).  8 
Among vertebrates, Danio rerio (zebrafish) has emerged as an outstanding model organism 9 
amenable to both forward and reverse genetic approaches. In addition, the natural transparency of the 10 
zebrafish embryo and larvae enables the unprecedented ability to non-invasively collect a rich set of 11 
expression data for the proteome and in the context of an entire living vertebrate. We describe here a 12 
1000+ collection of zebrafish lines made using the Protein Trap Gene- Breaking Transposon 13 
(GBT;(Clark, Balciunas, et al., 2011)to develop such a codex for the comparative vertebrate genomics 14 
field (Meadows & Lindblad-Toh, 2017), (Clark, Balciunas, et al., 2011).  15 
The initial pGBT-RP 2.1 (RP2.1) vector has several features that efficiency cooperate to report 16 
gene sequence, expression and function (Clark, Balciunas, et al., 2011). Two main reporter components 17 
include a 5’ protein trap and a 3’ exon trap, with the entire cassette flanked by inverted terminal repeats 18 
(ITR) of the miniTol2 transposon to effectively deliver the transgene as single copy integrations into the 19 
zebrafish genome. In cases where RP2 integrates in the sense orientation of a transcription unit, the 20 
protein trap’s splice acceptor overrides normal splicing of the transcription unit, creating a fusion 21 
between endogenous upstream exons and the monomeric RFP (mRFP) reporter sequences. The protein-22 
trap domain in RP2.1 generates the expression profile, including subsequent protein localization and 23 
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accumulation when a functional in-frame fusion between the start codon-deficient mRFP reporter and 1 
the tagged protein. Mutagenesis is accomplished by the strong internal polyadenylation and putative 2 
border element, effectively truncating the endogenously tagged protein. The GBT mutagenesis system 3 
represented the first step toward a ‘codex’ of protein expression and functional annotation of the 4 
vertebrate genome (Clark, Balciunas, et al., 2011). 5 
We report here the development of a series of GBT protein trap vectors including versions to trap 6 
expression in each of the three potential reading frames. In addition, we modified the 3’ exon trap to use 7 
a localized BFP rather than the more commonly used GFP to more effectively use these lines in 8 
conjunction with other transgenic fish. We deployed these vectors at scale, generating over 1000 protein 9 
trap lines with visible mRFP expression at either 2dpf (end of embryogenesis) or 4dpf (larval stage), 10 
with 36% and 87% of the cloned lines showcasing to our knowledge the first described expression of 11 
these genes at these stages, respectively. We used forward and reverse genetic tests to assess the 12 
mutagenicity of these vectors, noting similar rates of visible phenotypes at 5dpf as ENU and retroviral 13 
screening tools. We re-isolated five previously described loci, and embryos homozygous  for each of the 14 
corresponding GBT alleles displayed strong loss of function phenotypes comparable to these previously 15 
published mutants generated using other mutagenesis strategies (ryr1b, fras1, tnnt2a, edar and hmcn1). 16 
Molecular assessment after positional cloning shows that nearly all alleles cause at least a 99+% 17 
knockdown of the tagged gene. Interestingly, over 35% of the cloned loci represent 68 mutants in 18 
zebrafish orthologs of human disease loci, including nervous, cardiovascular, endocrine, digestive, 19 
musculoskeletal, immune and integument systems. The GBT protein trapping system enabled the 20 
construction of a comprehensive protein codex including novel expression annotation, identifying new 21 
functional roles of the vertebrate genome and generating a diverse collection of potential models of 22 
human disease.   23 
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Materials and Methods 1 
Zebrafish husbandry 2 
All zebrafish (Danio rerio) was maintained according to the guidelines and the standard procedures 3 
established by the Mayo Clinic Institutional Animal Care and Use Committee (Mayo IACUC). The 4 
Mayo IACUC approved all protocols involving live vertebrate animals (A23107, A21710 and A34513). 5 
Generating GBT constructs, RP2 and RP8 series 6 
pGBT-RP8.2 and -RP8.3 were made by combining three restriction endonuclease fragments of pGBT-7 
RP8.1, a 2.2 kb AflII to AgeI, a 0.7 kb EcoRI to SpeI, and a 3.0kb SpeI to AflII, with a short adapter to 8 
close the space between AgeI and EcoRI that effectively removed one or two thymine nucleotides just 9 
following the splice acceptor prior to the AUG-less mRFP cassette.  For pGBT-RP8.2, Adapter-10 
GBT(+2) was made by annealing oligos adapter-GBT(+2)-a 11 
[CCGGTTTTCTCATTCATTTACAGTCAGCCGG] and adapter-GBT (+2)-b 12 
[AATTCCGGCTGACTGTAAATGAATGAGAAAA].  For pGBT-RP8.3, Adapter-GBT(+3) was made 13 
by annealing oligos adapter-GBT (+3)-a [CCGGTTTTCTCATTCATTTACAGCAGCCGG] and 14 
adapter-GBT(+3)-b [AATTCCGGCTGCTGTAAATGAATGAGAAAA]. 15 
 16 
pGBT-RP2.2 and -RP2.3 were made by combining three restriction endonuclease fragments of pGBT-17 
RP2.1 (Clark, Balciunas, et al., 2011), a 3.6kb BlpI to AgeI, a 1.9kb EcoRI to AvrII, and a 3.55kb AvrII 18 
to BlpI, with a short adapter to close the space between AgeI and EcoRI that effectively removed one or 19 
two thymine nucleotides just following the splice acceptor prior to the AUG-less mRFP cassette. For 20 
pGBT-RP2.2, Adapter-GBT(+2) was made by annealing oligos adapter-GBT(+2)-a  and adapter-GBT 21 
(+2)-b .  For pGBT-RP2.3, Adapter-GBT(+3) was made by annealing oligos adapter-GBT (+3)-a and 22 
adapter-GBT(+3)-b.  23 
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 1 
pGBT-RP8.1 was made by cloning a mini-intron derived from carp beta actin intron 1 into pGBT-RP7.1.  2 
The 234bp SalI to XhoI mini-intron fragment was isolated from pCR4-bactmIntron following digestion. 3 
The pGBT-RP7.1 plasmid was digested with XhoI so that the SalI to XhoI fragment was cloned between 4 
the gamma-crystallin promoter and nls tagBFP. 5 
 6 
pCR4-bactmIntron was made by removing a 1.1kb internal portion of the carp beta actin intron 1 by 7 
digestion of pCR4-bact_I1 with BstBI and BssHII, followed by filling in 5’ overhangs and ligating 8 
remaining vector fragment. 9 
 10 
pCR4-bact_I1 was cloning a PCR product containing the carp beta-actin intron into pCR4-TOPO 11 
(Invitrogen).  The intron was amplified from pGBT-RP2.1 (Clark, Balciunas, et al., 2011) using MISC-12 
bact_exon-F1 [CAGCTAGTGCGGAATATCATCTGCC] and MISC-bact_intron-R1 13 
[CTTCTCGAGGTGAATTCCGGCTGAACTGTA] primers. 14 
 15 
pGBT-RP7.1 was made by replacing a 501bp PstI to PstI fragment of pGBT-RP6.1 with a 480bp PstI to 16 
PstI fragment of pRP2.1.  This changed the nucleotide sequence between the carp beta-actin splice 17 
acceptor to replicate the sequences in pGBT-RP2.1.  pGBT-RP7.1 was never directly tested in zebrafish. 18 
 19 
pGBT-RP6.1 was made by flipping the internal trap cassette relative the Tol2 inverted terminal repeats 20 
in pGBT-RP5.1.  To do this, pGBT-RP5.1 was cut with EcoRV and SmaI.  The 2.27kb EcoRV to SmaI 21 
vector backbone fragment, which included the ITRs, was ligated to the 3.51kb EcoRV to SmaI trap 22 
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fragment.  pGBT-RP6.1 was then selected based on the right ITR of Tol2 being in front of the RFP trap, 1 
which is the same orientation of pGBT-RP2.1. 2 
 3 
pGBT-RP5.1 was made by cloning a PCR product with the AUG-less mRFP into pre(-1)GBT-RP5.1.  4 
The 698bp mRFP* PCR product was obtained by amplification of pGBT-R15 (Clark, Balciunas, et al., 5 
2011) with CDS-mRFP*-F1 [AAGAATTCGAAGGTGCCTCCTCCGAGGATGTCATCAAGG] and 6 
CDS-mRFP-R1 [AAACTAGTCTTAGGCTCCGGTGGAGTGGCGG].  Prior to cloning the PCR 7 
mRFP* product was digested with EcoRI and SpeI to prepare the ends for subcloning into pre(-1)GBT-8 
RP5.1 that was opened between the carp beta actin splice acceptor and the ocean pout terminator. 9 
 10 
pre(-1)GBT-RP5.1 was made by cloning 1.2kb SpeI to AvrII fragment from pGBT-PX (Sivasubbu et al., 11 
2006) that contained the ocean pout terminator into the SpeI site of pre(-2)GBT-RP5.1. The resulting 12 
products were screened for the proper orientation of the ocean pout terminator relative to the carp beta 13 
actin splice acceptor. 14 
 15 
pre(-2)GBT-RP5.1 was made by inserting an expression cassette to make a 3’ poly(A) trap that makes 16 
blue lenses.  A 1.15kb SpeI to BglII fragment from pKTol2gC-nlsTagBFP was cloned into pre(-3)GBT-17 
RP5.1 that had been cut with AvrII and BglII.  This moved the Xenopus gamma crystallin promoter 18 
driving a nuclear-localized TagBFP in front of the carp beta actin splice donor within pre(-3)GBT-RP5.1 19 
to create a localized BFP poly(A) trap signal replacing the ubiquitous GFP signal that was in pGBT-20 
RP2.1. 21 
 22 
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pre(-3)GBT-RP5.1 was made by cloning a 492bp XmaI to NheI scaffold fragment from pUC57-I-1 
SceI_loxP_splice into pKTol2-SE (Clark, Balciunas, et al., 2011) opened with XmaI and NheI.   2 
pUC57-I-SceI_LoxP_Splice contains a synthetic sequence (see below) cloned into pUC57 (Genscript).  3 
The scaffold contains an I-SceI site; loxP site; carp beta actin splice acceptor; cloning sites for mRFP, 4 
ocean pout terminator, and BFP lens cassettes; carp beta actin splice donor; loxP site; and an I-SceI site. 5 
[cccgggatagggataacagggtaatataacttcgtatagcatacattatacgaagttatcgttaccacccactagcggtcagactgcagattgcagcac6 
gaaacaggaagctgactccacatggtcacatgctcactgaagtgttgacttccctgacagctgtgcactttctaaaccggttttctcattcatttacagttca7 
gcctgttacctgcactcaccgacaagctgttaccctggaattcgtttaaacactagtcaccggcgttcctaggttataagatctacctaaggtgagttgatct8 
ttaagctttttacattttcagctcgcatatatcaattcgaacgtttaattagaatgtttaaataaagctagattaaatgattaggctcagttaccggtcttttttttct9 
catttacactgagctcaagacgtctgataacttcgtatagcatacattatacgaagttattaccctgttatccctatggctagc] 10 
 11 
Generating GBT collection 12 
Generation of the GBT collection was based on the prior described protocols (Clark, Balciunas, et al., 13 
2011; Clark, Urban, Skuster, & Ekker, 2011; J. Ni et al., 2016). 14 
 15 
Fluorescent microscopy of mRFP reporter protein expression  16 
Larvae were treated with 0.2 mM phenylthiocarbamide at 1 dpf to inhibit pigment formation. The 17 
anesthetized fish were mounted in 1.5% agarose (Fisher Scientific BP1360) prepared with 0.017mg/ml 18 
tricaine solution in an agarose column in the imaging chamber. The protocol of ApoTome microscopy 19 
was described in previous publication. (Clark, Balciunas, et al., 2011) For Lightsheet microscopy, larval 20 
zebrafish were anesthetized with 0.017g/ml tricaine (Ethyl 3-aminobenzoate methanesulfonate salt) in 21 
embryo water during imaging procedure. To capture RFP expression patterns of 2 dpf and 4 dpf larval 22 
zebrafish, LP 560 nm filter as excitation and LP 585nm as emission was used for Lightsheet microscopy. 23 
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The sagittal-, dorsal-, and ventral- oriented z-stacks of the mRFP expression were captured at either 50x 1 
magnification using an ApoTome microscope (Zeiss) with a 5x/0.25 NA dry objective (Zeiss) or 50x 2 
magnification using a Lightsheet Z.1 microscope (Zeiss) 5x/0.16 NA dry objective. Each set of images 3 
were obtained from the same larva and the images shown are composites of the maximum image 4 
projections of the z-stacks obtained from each direction.  5 
 6 
Sperm Cryopreservation 7 
Sperm collection and cryopreservation was initially based on the protocol described in (Draper & Moens, 8 
2009) and moved to the ZIRC protocol described in (Matthews et al., 2018).  9 
 10 
Genomic DNA isolation 11 
Genomic DNA was isolated from F1 fish tail biopsies to conduct next generation sequencing and from 12 
both WT and heterozygous larva to manually perform the PCR-based mRFP linkage analysis. Zebrafish 13 
larva were individually placed to 0.2 ml PCR tubes and sacrificed to extract genomic DNA in 50 mM 14 
NaOH for 20 min at 95 C
o
.  15 
 16 
PCR-based linkage analysis of GBT insertions loci 17 
TALE-PCR: The protocol used was designed to amplify and clone junction fragments from Tol2-based 18 
gene-break transposons (GBT) in the zebrafish genome. Although modified, it is based on a protocols 19 
received from Alexi Parnov, Vladimir Korsch, and Karuna Sampath. The following primer mixtures 20 
(containing 0.4 μM GBT specific primer and 2 µM DP primer) were prepared: for primary PCR: 5R-21 
mRFP-P1/DP1, 5R-mRFP-P1/DP2, 5R-mRFP-P1/DP3, 5R-mRFP-P1/DP4, 3R-GM2-P1/DP1, 3R-22 
GM2-P1/DP2, 3R-GM2-P1/DP3, 3R-GM2-P1/DP4,  3R-tagBFP-P1/DP1, 3R-tagBFP-P1/DP2, 3R-23 
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tagBFP-P1/DP3, 3R-tagBFP-P1/DP4 ; for secondary PCR: 5R-mRFP-P2/DP1, 5R-mRFP-P2/DP2, 5R-1 
mRFP-P2/DP3, 5R-mRFP-P2/DP4, 3R-GM2-P2/DP1, 3R-GM2-P2/DP2, 3R-GM2-P2/DP3, 3R-GM2-2 
P2/DP4, 3R-tagBFP-P2/DP1, 3R-tagBFP-P2/DP2, 3R-tagBFP-P2/DP3, 3R-tagBFP-P2/DP4;  for tertiary 3 
PCR:  TAIL-bA-SA/DP1, TAIL-bA-SA/DP2, TAIL-bA-SA/DP3, TAIL-bA-SA/DP4, Tol2-ITR(L)-4 
O1/DP1, Tol2-ITR(L)-O1/DP2, Tol2-ITR(L)-O1/DP3, Tol2-ITR(L)-O1/DP4, Tol2-ITR(L)-O3/DP1, 5 
Tol2-ITR(L)-O3/DP2, Tol2-ITR(L)-O3/DP3, Tol2-ITR(L)-O3/DP4.  A total of 1 μl of primer mixtures 6 
were added to PCR reaction (total volume 25 µl). Cycle settings were as follows. Primary: (1) 95°C, 3 7 
min; (2) 95°C, 20 sec; (3) 61°C, 30 sec; (4) 70°C, 3 min; (5) go to “cycle 2” 5 times; (6) 95°C, 20 sec; 8 
(7) 25°C, 3 min; (8) ramping 0.3°/sec to 70°C; (9) 70°C, 3 min; (10) 95°C, 20 sec; (11) 61°C, 30 sec; 9 
(12) 70°C, 3 min; (13) 95°C, 20 sec; (14) 61°C, 30 sec; (15) 70°C, 3 min; (16) 95°C, 20 sec; (17) 44°C, 10 
1 min; (18) 70°C, 3 min; (19) go to “cycle 10” 15 times; (20) 70°C, 5 min; Soak at 12 °C . A total of 5 11 
μl of the primary reaction was diluted with 95 µl of 10mM Tris-Cl or TE buffers and 1μl of the mixture 12 
was added to the secondary reaction. Secondary: (1) 95°C, 2 min (2) 95°C, 20 sec; (3)61°C, 30 sec; (4) 13 
70°C, 3 min; (5) 95°C, 20 sec; (6) 61°C, 30 sec ; (7) 70°C, 3 min; (8) 95°C, 20 sec; (9) 44°C, 1 min; 14 
(10) ramping 1.5°/sec to 70°C; (11) 70°C, 3 min; (12) go to “cycle 2” 15times; (13) 70°C, 5 min;  Soak 15 
at 12°C. A total of 5 μl of the primary reaction was diluted with 95 µl of 10mM Tris-Cl or TE buffers 16 
and 1μl of the mixture was added to the tertiary reaction. Tertiary: (1) 95°C, 2 min; (2) 95°C, 20 sec; (3) 17 
44°C, 1 min; (3) ramping 1.5°/sec to 70°C; (4) 70°C, 3 min; (5) go to “cycle 2” 32 times; (6) 70°C, 5 18 
min; Soak at 12°C. Products of the secondary and tertiary reactions were separated by using 1-1.5% 19 
agarose gel. The individual bands from the “band shift” pairs were cut from the gel and purified by 20 
using QIAquick Gel Extraction Kit (QIAGEN, Germany), and sequenced by using ABI Cycle 21 
Sequencing chemistry (PE Applied Biosystems, CA) and an ABI Prism 310 Genetic Analyzer with Data 22 
Collection Software (PE Applied Biosystems, Foster City, CA) supplied by the producer. 23 
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5’ and 3’ RACE PCRs: The protocol used was designed to use cDNA to amplify and clone junction 1 
fragments of Tol2-based gene-break transposons (GBT) in the zebrafish genome. 5' RACE allows PCR 2 
amplification of unknown sequence at the 5' end of a cDNA as long as there is enough known sequence 3 
within the cDNA to design two antisense primers. Although modified, it is based on the protocol in 4 
described in (Clark, Balciunas, et al., 2011). The following primer mixtures were prepared: for primary 5 
PCR: 0.20 μM GBT specific primer (5R-mRFP-P1), and a mix of universal 5’ RACE primers 2.5 μM 6 
5R-UP-S and 0.5 μM 5R-UP-L . Secondary reaction: 25 μM GSP (5R-mRFP-P2), and 25 μM universal 7 
primer 5R-N1. The reaction mix used was as follows: Primary: (25 μl reaction) Template (RR-cDNA) 2 8 
μl, Bioline 5X myTaq buffer 5 μl, myTaq 0.25 μl, GSP 0.5 μl, Universal 5’ RACE primer mix (URS 9 
mix) 2.0 μl, Water 15.25 μl. Secondary: (50 μl reaction) Template (2:100 dilution 1° PCR Reaction), 10 
Bioline 5X myTaq buffer 10 μl, myTaq 0.3 μl, GSP-P2 0.9 μl, URS-P2 0.9 μl, Water 35.9 μl. Cycle 11 
Settings are as follows. Primary: (1) 95°, 3'; (2) 95°, 30"; (3) 65°, 30" -0.5°/cycle; (4) 70°, 2'; Go To (2) 12 
x 15 cycles; (5) 95°, 30"; (6) 57°, 30"; (7) 70°, 2'; Go To (5) x 20 cycles, (8) 70°, 10'; (9) Soak at 12°. 13 
Dilute 2µL of the primary PCR reaction with 198µL of 10mM Tris-Cl; 1mM EDTA pH8.0. Secondary: 14 
(1) 95° for 3' (2) 95°, 30"; (3) 63°, 30" -0.5°/cycle; (4) 70°, 2'; Go To (2) x 10 cycles; (5) 95°, 30"; (6) 15 
58°, 30"; (7) 70°, 2'; Go To (5) x 25 cycles; (8) 70°, 10'; Soak at 12°. After the PCR reactions finish 16 
20µL of each sample were run on a 1.2% agarose gel. You may also run 10µL of undiluted primary 17 
PCR reactions on the same gel; however, most of the time the bands of interest do not all appear until 18 
after the nested PCR reactions have been run. The individual bands from the gel were excised and 19 
purified by using QIAquick Gel Extraction Kit (QIAGEN, Germany), and sequenced by using ABI 20 
Cycle Sequencing chemistry (PE Applied Biosystems, CA) and an ABI Prism 310 Genetic Analyzer 21 
with Data Collection Software (PE Applied Biosystems, Foster City, CA) supplied by the producer. 22 
 23 
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Forward genetic screening with next-generation sequencing  1 
Isolated genomic DNA (300-500ng) was digested with MseI, and BfaI in parallel for 3h at 37°C and 2 
heat inactivated for 10 min at 80°C. The digested samples from each enzyme were pooled with 3 
prealiquoted barcoded linker in individual wells. The T4 DNA ligase (New England Biolabs, Inc.) was 4 
added, and the reaction mix was incubated for 2 h at 16°C. The linker-mediated PCR was performed in 5 
two steps. In the first step, PCR was done with one primer specific to the 3’- ITR (5’- 6 
GACTTGTGGTCTCGCTGTTCCTTGG-3’) and the other primer specific to linker sequences (5’-7 
GTAATACGACTCACTATAGGGC- 3’) using the following conditions: 2 min at 95°C, 25 cycles of 15 8 
sec at 95°C, 30 seconds at 55°C and 30 seconds at 72°C. The PCR products were diluted to 1:50 in 9 
dH2O, and a second round of PCR was performed using ITR (5’-10 
TCACTTGAGTAAAATTTTTGAGTACTTTTTACACCTC-3’) and linker specific (5’ - 11 
GCGTGGTCGACTGCGCAT-3’) nested primers to increase sensitivity and avoid non- specific 12 
amplification using the following conditions: 2 min at 95°C, 20 cycles of 15 sec at 95°C, 30 seconds at 13 
58°C and 30 seconds at 72°C. The nested PCR products from each 96-well plate are pooled and 14 
processed for Illumina library preparation as per manufacturer’s instructions. 15 
 16 
Protein classification of the cloned zebrafish genes 17 
The 183 cloned zebrafish genes are classified by using PANTHER (Mi, Muruganujan, & Thomas, 2013). 18 
PANTHER provided protein classes of the molecule coded by the cloned zebrafish genes. 19 
 20 
Annotating human orthologues of GBT-tagged genes and disease-causing genes  21 
The human orthologues of 192 cloned zebrafish genes were mainly collected by using a data mining tool, 22 
ZebrafishMine (Van Slyke et al., 2018) supported by the ZFIN database. In some cases, the candidates 23 
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of human orthologues unlisted in ZFIN database were manually searched by using both Ensembl 1 
(https://useast.ensembl.org/index.html) and InParanoid8 (http://inparanoid.sbc.su.se/cgi-bin/index.cgi) 2 
databases. In parallel, the candidates were manually identified by the result of BLASTP assembled with 3 
human proteins and by the result of an online synteny analysis tool, SynFind 4 
(https://genomevolution.org/CoGe/SynFind.pl). If the candidate multiply hit in those manual 5 
assessments, it was annotated as a human orthologue. The human phenotype data caused by mutations 6 
of 68 human orthologues were collected by using another data mining tool, BioMart 7 
(http://useast.ensembl.org/biomart/martview/cfe15ead83199a0b7c7997f5a4ce9e6b) supported by 8 
Ensembl database.  9 
 10 
Finding Disease Models in Vertebrates 11 
Mouse models were found by using both descriptions of animal models in Online Mendelian Inheritance 12 
in Man (OMIM; https://www.omim.org/) and in Mouse Genome Informatics (MGI; 13 
http://www.informatics.jax.org/humanDisease.shtml). MGI provided the details of mouse models of 14 
human disease, such as the number of models have been established. Zebrafish model were also found 15 
by using both OMIM and the Zebrafish Information Network (ZFIN; https://zfin.org/). ZFIN provided 16 
all data of fish strains listed in this database.  17 
  18 
Gene expression profiling of the cloned zebrafish genes 19 
The cloned genes with unpublished expression data were isolated by using “Gene Expression” tool of 20 
ZebrafishMine (Van Slyke et al., 2018). In parallel, some published expression data were also manually 21 
searched from ZFIN database or in some references. To isolate the gene with the expression localized in 22 
the tissues or the organs shows abnormalities in the causing diseases of the human orthologues, the 23 
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mRFP reporter expression patterns of the cloned genes 2 and 4 dpf are manually analyzed using 1 
zfishbook database (Clark, Argue, Petzold, & Ekker, 2012).  2 
  3 
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Results 1 
The features of GBT constructs RP2 and RP8 – capturing all three proteomic reading frames 2 
In our previous study, we reported the intronic-based gene-breaking transposons (GBTs) as effective and 3 
revertible loss-of function tools for zebrafish (Clark, Balciunas, et al., 2011). The main features of the 4 
RP2.1 vector system are as follows (Fig1A): 1) Genetically engineered cargo is flanked by miniTol2 5 
sequences necessary and sufficient for Tol2 transposase-mediated transposition, an efficient transgenesis 6 
vector in zebrafish (Kawakami et al., 2004); (Balciunas et al., 2006); (Urasaki, Morvan, & Kawakami, 7 
2006); 2) protein trap that enables in vivo expression selection of the vertebrate proteome. The addition 8 
of the AUG-free mRFP reporter has yielded an effective protein trap for both organ-specific and 9 
subcellular localization of the tagged locus (Petzold et al., 2009); (Clark, Balciunas, et al., 2011); (Liao 10 
et al., 2012);(Xu et al., 2012);(Ding et al., 2013); (Westcot et al., 2015); 3) Mutagenic transcriptional 11 
terminator. The 5’ cassette is a combination of a strong splice-acceptor (SA), poly adenylation signal 12 
(pA), and putative border element (red octagon) in conjunction with a start codon (AUG)-free 13 
monomeric red fluorescent protein (mRFP) reporter. These elements have been shown to be effective as 14 
a transcriptional stop in zebrafish by hijacking endogenous splicing (Sivasubbu et al., 2006). These 15 
elements are very effective at inducing a quantitative knockdown in all 26 lines assessed to date using 16 
qRT-PCR; 97% or higher knockdown in all lines (Clark, Balciunas, et al., 2011); (Ding et al., 2013); 17 
(Ding et al., 2016), this manuscript). The GBT mutagenesis system is thus an effective first step to 18 
creating a gene codex simultaneously combining expression and loss of function genetics.  19 
However, some limitations were noted with the initial RP2.1 vector – notably the effective trapping of 20 
transcripts without detectable expression of the mRFP reporter. Molecular cloning of these GFP+/RFP- 21 
lines demonstrated the fidelity of expression requiring the capture of an appropriate reading frame. 22 
RP2.1 was designed to use one main reading frame, and some lines with expression were noted to 23 
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include the use of a secondary splice acceptor (data not shown). To maximize genome coverage of this 1 
insertional mutagen, we created all three reading frames of the RP2 and RP8 vector series (Fig. 1). 4) 3’ 2 
exon trap. These vectors also encodes a 3’ exon trap with preferential expression following intragenic 3 
insertions in zebrafish (Sivasubbu et al., 2006); (Petzold et al., 2009); (Clark, Balciunas, et al., 2011). 4 
The function of this cassette complements the obligate, in-frame protein trapping effect and is used for 5 
both quality control during mutagenesis and for genotyping of more weakly expressing protein trap 6 
alleles (Fig.1A). In the RP2 vector series, the nearly ubiquitous b-actin promoter drives expression of 7 
GFP. Expression of integrated GFP becomes detectable between early developmental stages such as 8 
seven- to eight-somite-stage and provides bright expression with a good signal-to-noise ratio at 25 hpf 9 
(Davidson AE et al., 2003). However, the ubiquitous GFP expression from the 3’ exon trap cassettes 10 
could interfere with another fluorescent marker system based on GFP labeling in further studies. The 11 
RP8 vector series includes all reading frames for the AUG-free mRFP reporter and a new 3’ exon trap 12 
cassette with expression of tagBFP driven by the lens-specific gamma-crystalline promoter (Fig. 1B). 13 
Using the tissue-specific reporter system with BFP is helpful to easily detect F1 founder with weak 14 
mRFP expression and to avoid interference with GFP-based multi-labeling purposes when crossed with 15 
other GFP-labeled transgenic fish lines. 5) Revertible mutagenic cassette. The flanking loxP sites enable 16 
reversion of the tagged locus by Cre – mediated recombination. This facilitates both somatic (Clark, 17 
Balciunas, et al., 2011); (Ding et al., 2013) and germline approaches (Petzold et al., 2009).  18 
We generated more than eleven hundred independent lines by using all six constructs of the GBT system 19 
(Supplemental Table 1). We conducted an initial screening expression of the mRFP fusion protein and 20 
showed that RP2 and RP8 vector series with all reading frames of mRFP reporter protein readily detects 21 
the distribution of the fusion proteins expressed from their own promoter in zebrafish (Supplemental 22 
Figure 1).  23 
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 1 
Annotation of protein localization and trafficking of the GBT strain collection 2 
The ability to non-invasively obtain temporal and spatial expression pattern information is a key feature 3 
of these protein trap strains. Pilot data from our first RFP lines rapidly demonstrated this step was going 4 
to be a major bottleneck for our pipeline if we used standard documentation methods. Consequently, we 5 
established a capillary-based confinement and imaging protocol (SCORE imaging; (Petzold et al., 2010) 6 
for quickly capturing and holding living zebrafish for rapid, high quality fluorescent expression in 7 
precise longitudinal imaging angles. The animals are easily inserted into a capillary of the correct 8 
diameter for the particular fish stage, then placed on the microscope and covered with a matched 9 
solution to remove the optical distortion from the capillary housing. The capillary is simply rotated for 10 
precise 0 degree (dorsal), 90 degree (lateral), and 180 degree (ventral) images on standard fluorescent 11 
microscopes, such as the Apotome. The technical bottleneck of standard microscopy to scan a whole 12 
embryo and larva is also labor-intensive and time-consuming. For instance, fluorescent scanning of a 13 
quarter of a 2dpf or 4dpf larvae required about 15 min exposure using a Zeiss Apotome microscope, one 14 
imaging modality deployed for this collection. To accelerate the expression profiling of these GBT lines, 15 
we subsequently utilized a Zeiss Lightsheet Z.1 SPIM microscope. The Lightsheet enabled high speed 16 
scanning of a whole embryo or larva, resulting in a nearly 20x faster image acquisition rate than the 17 
primary imaging process utilizing the Apotome. We prioritized and cataloged lines with robust 18 
expression at 2 and 4 days post fertilization (dpf). All zebrafish lines are freely available now through 19 
zfishbook (Clark et al., 2012) and are partially accessible from the Zebrafish International Resource 20 
Center. Consequently, we have generated 1138 lines by using each vector system showing in 21 
Supplemental Table 1), and updated results are posted at zfishbook.    22 
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Our throughput for cloning the GBT lines using traditional molecular methods was clearly an initial 1 
bottleneck. To help address this, we deployed a rapid cloning process based on methods used to isolate 2 
retroviral integrations (Varshney, Huang, et al., 2013; Varshney, Lu, et al., 2013). This method 3 
leverages the massive parallel sequencing technology of the Illumina MiSeq, yielding 101 bp 4 
sequencing reads, followed by a custom bioinformatics pipeline that involves both mapping and 5 
annotation. Fin-clips from four male animals per GBT locus are obtained during sperm cryopreservation 6 
and are used as a source of DNA. Shared inserts in multiple individuals from a single GBT line are 7 
considered candidate loci. This information is subsequently used to generate gene-specific primers to 8 
manually confirm linkage using 5‘ or 3’RACE, inverse PCR, or TAIL PCR to generate locus-specific 9 
primers for downstream molecular genotyping applications. 212 of the lines met the highest stringency 10 
of confirmed expression linkage and are classified as confirmed GBT integrations. An additional 143 11 
lines have been initially tagged using this high throughput method, yielding candidate integration 12 
annotation as listed in zfishbook. The ability to complete the annotation status from candidate to 13 
confirmed for any given GBT locus with a desired expression profile is enhanced by the continued 14 
refinement of the zebrafish genome.  15 
 16 
mRFP Expression profiling reveals overlap with known annotation at 2dpf and substantive new 17 
expression data at both 2dpf and 4dpf 18 
GBT lines are currently imaged to capture mRFP expression at both 2 and 4 dpf, including dorsal, 19 
sagittal and ventral views using the SCORE imaging method. (Petzold et al., 2010) In an openly 20 
accessible database of GBT lines, zfishbook, the images of mRFP expression pattern were stored within 21 
the media gallery associated with each line (Clark et al., 2012).  We summarized published expression 22 
data of the tagged genes in both zfishbook and ZFIN in Table 1. Imaging the localization of transcripts 23 
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and proteins at 4dpf is more difficult than those at 2 dpf, because accessibility of antisense RNA probes 1 
and antibodies into the larva’s body is technically limited for in the methods of both in situ hybridization 2 
and immunohistochemistry. Compared with the published data of gene expression in ZFIN, zfishbook 3 
currently provides almost the double number of genes with expression data at 2 dpf and 14 times the 4 
number of genes with expression data at 4 dpf (Table 1). In addition, zfishbook also provides novel 5 
expression data for 61 genes at any developmental stage (Fig.2). 6 
  7 
High knockdown efficiency of endogenous transcripts induced by RP2 8 
We directly compared published transposon insertional mutant vector systems (Fig. 3). The range and 9 
average knockdown levels in the FlipTrap system (Trinh le et al., 2011) produced a range of 4-30% (70-10 
96% knockdown capacity) in six tested fish alleles, a similar range to our initial R-series protein trap 11 
vectors (R14-R15) that used a simple transcriptional terminator (Liao et al., 2012; Petzold et al., 2009) 12 
The pFT1 appears to be an improvement over these systems, in which the overall range and average 13 
read-through is reduced to 6-11% (89-94% knockdown) from four tested fish alleles (T. T. Ni et al., 14 
2012). In contrast, the RP2.1 vector (Clark, Balciunas, et al., 2011), (Ding et al., 2013), (Ding et al., 15 
2016) and this manuscript) maintains a strong knockdown (1% or less read-through) in 26 lines tested. 16 
Though deployed here using a nearly random, transposon-based delivery platform, the GBT vector 17 
system is an effective insertional mutagen suitable for an array of other – including targeted integration - 18 
genome-wide applications. 19 
 20 
Phenotypic Appearance Rate is Similar to Other Mutagenic Technologies for Forward Genetics 21 
Screening through 5 dpf  22 
.CC-BY 4.0 International licenseis made available under a
The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. It. https://doi.org/10.1101/630236doi: bioRxiv preprint 
22 
 
 We conducted an initial forward genetic screen on embryos and early larvae of 179 RFP-positive GBT 1 
lines, identifying 12 recessive phenotypes, such as ryr1b,  fras1,  tnnt2a,  edar and  hmcn1,(Clark, 2 
Balciunas, et al., 2011; Westcot et al., 2015)  visible during the first five days of development including 3 
lethality, heart, muscle, skin and other phenotypes. This 7% recovery of visible early developmental 4 
mutants is very similar to the 5% recovered visible mutants from the Sanger TILLING consortium 5 
analysis of truncated zebrafish genes (Kettleborough et al., 2013). This 7% is also comparable to prior 6 
retroviral (Amsterdam & Hopkins, 2004) and ENU(Haffter et al., 1996) zebrafish mutagenesis work that 7 
estimated between 1400 and 2400 genes (~5-9% of the genome) would result in a visible embryonic 8 
phenotype when mutated. 9 
 10 
GBT alleles phenocopy known embryonic mutations 11 
We tested the first five GBT lines in genes with known loss of function mutant phenotypes (ryr1b; 12 
fras1; tnnt2a; edar; hmcn1). All five of these alleles in genes with described loss of function defects are 13 
phenocopied by these GBT insertional alleles (Clark, Balciunas, et al., 2011); (Westcot et al., 2015); this 14 
manuscript). These loci represent a critical internal methods reference further validating the 15 
mutagenicity of these novel insertional vectors. 16 
 17 
Gene ontology analysis of GBT-tagged loci 18 
To assess the diversity of GBT loci molecularly characterized to date, we utilized the PANTHER 19 
classification system (v.14.0, pantherdb.org , (Mi et al., 2013) and generated a table of protein class 20 
ontology tags in the molecularly isolated GBT lines. The PANTHER Protein Class ontology was 21 
adapted from the PANTHER INDEX (PANTHER/X) ontology that comprises two types of 22 
classifications: molecular function and biological process and includes commonly used classes of 23 
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protein families. The molecular function schema classifies a protein based on its biochemical properties, 1 
such as receptor, cell adhesion molecule, or kinase. The biological process schema classifies a protein 2 
based on the cellular role or process in which it is involved, for example, carbohydrate metabolism 3 
(cellular role), TCA cycle (pathway), neuronal activities (process), or developmental processes (process) 4 
(Thomas PD et al, 2013). As of April 2018, almost half of  known zebrafish genes (10626/25289 genes) 5 
were tagged in the PANTHER Protein Class ontology. 168 of our cloned GBT alleles mapped in the 6 
PANTHER system with 21 types of Protein Classes (Table 2). 18% and 16 % of the mapped GBT 7 
alleles are classified to nucleic acid binding (PC00171) and transcription factor (PC00218), respectively 8 
(Fig. 4). This result reveals that a quarter of the mapped genes possibly play a role in regulatory 9 
processes. Overall, however, the rich diversity of protein classes observed in our cloned traps suggests a 10 
large diversity will be represented by the overall collection and consistent with the random nature of 11 
genome integration events by the Tol2 transposon (Clark, Balciunas, et al., 2011). 12 
 13 
Disease-causing human orthologues of GBT-tagged genes 14 
Of 183 GBT-tagged genes, 171 human orthologues were annotated in at least one public database such 15 
as ZFIN, Ensembl, Homologene, and InParanoid (Table 3). Several human orthologues were 16 
provisionally annotated using BLASTP and a synteny analysis tool, SynFind. In a previous study 17 
comparing the list of human genes possessing at least one zebrafish orthologue with the 3,176 genes 18 
bearing morbidity descriptions that are listed in the OMIM database, 82 % morbid genes 2,601 genes) 19 
can be related to at least one zebrafish orthologue (Howe et al., 2013). Surprisingly, 67 genes (about 20 
37%)  of 183 annotated human orthologues are associated with human disease involved in multi-organ 21 
system including nervous, circulatory, endocrine, metabolic, digestive, musculoskeletal, immune, and 22 
integument systems (Fig. 5  and Table 3) and many are not established in rodents and zebrafish (Table 23 
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5). The GBT protein-trap system provides a variety of potential human disease models which have a 1 
revertible allele that can interchange between disease and healthy cellular, organ and physiological states.        2 
 3 
The GBT Protein Trap Reveals Protein-Coding Regions Not Predicted by the Zebrafish Genome 4 
Project 5 
16 of 211 molecularly confirmed lines by manual, PCR-based mRFP linkage analysis using TALE, 6 
inverse, and RACE PCRs (Table 4) do not match any expressed sequence tag (EST) or predicted genes. 7 
However, in each case we were able to confirm transcription at the locus in wild-type animals, yielding 8 
new annotation for these loci in the zebrafish genome.    9 
  10 
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Discussions 1 
Novel Expression Annotation Revealed By Protein Trapping of Endogenous Genes 2 
The RP2 and RP8 vectors of GBT system were assembled to capture all three reading frames of fusion 3 
protein of the trapped gene with the mRFP reporter. This GBT system reveals that mRFP-truncated 4 
fusion proteins exhibit distinct subcellular localization. This is particularly noteworthy for the 4dpf 5 
stages because published gene expression data at late developmental stages have been limited by the 6 
technical difficulties in conducting such analyses using traditional techniques such as whole mount in 7 
situ hybridization (WISH) at these larval and later time points. We note that the mRFP-truncated fusion 8 
protein may localize ectopically in cases where the protein localization signal is contained in the C-9 
terminal domain (Clark, Balciunas, et al., 2011; Trinh le & Fraser, 2013). Although the extent that 10 
subcellular localization recapitulates the endogenous protein is dependent on each insertion locus 11 
specifics, the visualizing and illuminating spatiotemporal expression patterns of trapped protein may 12 
facilitate dynamic studies of specific cell types and molecular functions in a living vertebrate. The novel 13 
expression description at 4dpf in nearly five of six cloned loci demonstrates the dearth of 3D expression 14 
annotation for the overwhelming number of genes, even in one of the most studied model system such as 15 
the zebrafish. With ever-improving microscope-based imaging tools (Liu et al., 2018), these lines have 16 
the potential to help annotate at diverse developmental and adult stages, while also potentially imaging 17 
subcellular expression for a subset of protein trap fusions. 18 
 19 
Gene-Break Protein Trap in an Effective Insertional Mutagen with High Knockdown Efficiency 20 
and Cre-Reversion to WT allele    21 
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Transposons offer several unique features over and above traditional static mutational approaches, 1 
including high quality expression tools and new regulated mutagenesis methodologies. From the 2 
perspective of genome engineering development, GBT technology was the first method for revertible 3 
allele generation of vertebrates outside of the mouse (Clark, Balciunas, et al., 2011); (Ding et al., 2013). 4 
We know two major potential biases that may yield non-random trapping coverage of the genome. First, 5 
the RP2.1 protein trap was initially designed around a single reading frame. Upon molecular analysis of 6 
our first lines, however, we discovered that RP2.1 encodes a second, alternative splice acceptor yielding 7 
protein trap expression from a second reading frame due to this alternative splicing event in a significant 8 
number of our lines. The deliberate development of RP2 and RP8 vectors for each reading frame 9 
obviates this potential limitation when used in other delivery modalities besides the Tol2 transposon. For 10 
example, these vectors would be suitable for gene editing-based targeted knockin methods. 11 
The GBT system deployed here has been joined by two new and complementary transposon 12 
mutagenesis systems. The FlipTrap system by Dr. Fraser’s group(Trinh le et al., 2011), which can be 13 
mutagenic when provided Cre recombinase, is primarily focused on imaging fusion proteins in vivo and 14 
addressing cellular dynamics and related questions. The FT1 system by the Chen lab is a complementary 15 
flipping trap that can use either Cre or Flp recombinases to regulate alleles depend on the original 16 
orientation of the insertion (T. T. Ni et al., 2012). GBT-based zebrafish alleles are highly 17 
complementary and non-redundant to those generated by other mutagenesis methods, including these 18 
other transposons and demonstrated higher knockdown efficiency of the WT transcripts than those 19 
mutagens because of the use of an enhanced polyadenylation signal and a putative boundary element 20 
between 5’ protein trap and 3’ exon trap cassettes. Importantly, since the initiation of this project to 21 
generate a collection of Cre-revertible mutant alleles, several groups have now reported collections of 22 
tissue-specific Cre driver lines including the Brand lab (Jungke et al., 2013; http://crezoo.crt-23 
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dresden.de/crezoo/), the Zcre consortium (http://zcre.org.uk/) and the Wen lab in the PTC Consortium . 1 
The GBT system described here is a two-component, molecularly regulatable mutagenesis approach that 2 
offers the ability to test for the sufficiency of protein-encoding loci in regulated, tissue- and cell- specific 3 
applications. 4 
 5 
Functional Diversity of the Trapped Proteins by the GBT system 6 
To analyze distribution of protein functions of the trapped genes by GBT system, we performed GO 7 
analysis using the PANTHER protein classification. Although the protein functions related in 8 
transcriptional regulatory process, such as nucleic acid binding and transcription factors represented one 9 
relatively common class of isolated genes, the protein GO analysis indicated that the GBT protein trap 10 
was a useful tool for capturing a wide range of protein functions in addition to cell fate regulators and 11 
related nuclear genes. 12 
 13 
Cloned GBT Loci Represent a Rich Collection of Potential Human Disease Models  14 
More than 7,000 human diseases have already been described, and 80% of those are thought to have a 15 
genetic origin (Varga et al., 2018). Model organism studies can be a pivotal resource for understanding 16 
gene function which possibly provides additional insight into the cause of particular disease, thereby 17 
contributing to understanding of the pathogenic process and discovery of the therapeutic strategy 18 
(Wangler et al., 2017). Annotation of human orthologues of 160 tagged genes revealed that GBT 19 
technology yield a high frequency potential human disease models with loss of gene function, tracking 20 
expression of the truncated protein and Cre-revertible mutated allele to rescue the phenotype. 21 
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Furthermore, the modeling human genetic diseases using the GBT system has advantages compared 1 
with reverse genetic approaches such as TALEN and CRISPR-Cas9 systems. In initial phenotype 2 
screening, PR2.1 mutagenesis demonstrated 7% phenotype appearance as much as the other ENU- and 3 
retroviral forward genetic screenings (Amsterdam & Hopkins, 2004; Haffter et al., 1996; Kettleborough 4 
et al., 2013). For example, the annotation of disease-causing human orthologues of the tagged genes also 5 
revealed that the GBT system comprehensively developed mutants in zebrafish orthologues of human 6 
disease loci, including nervous, cardiovascular, endocrine, digestive, musculoskeletal, immune, and 7 
integument systems. Surprisingly, this system generated 68 of pioneering mutants in orthologs of human 8 
disease loci (Supplemental Table 2). 9 
 10 
Discovery of Novel Transcripts by Trapping Unpredicted Genes 11 
Since the completion of the zebrafish reference genome sequencing, it has enabled many new 12 
discoveries to be made, in particular the positional cloning of hundreds genes from mutation affecting 13 
embryogenesis behavior, physiology, and health and disease. However, a few poorly assembled regions 14 
remain (Howe et al., 2013). In molecular cloning of GBT lines generated, we found that a surprising 15 
proportion of the sequenced insertions does not correspond to any predicted genes. Although we have 16 
not formally excluded that mRFP expression might, in some case, be an artifact, the data of gene 17 
prediction provided in genome databases reveals some prediction errors. These results suggest that the 18 
algorithms used to predict genes from genome databases have missed a significant number of genes. The 19 
protein trapping by using GBT system may useful in identifying unsuspected novel genes, expressions 20 
and functions in vivo in real time. 21 
 22 
.CC-BY 4.0 International licenseis made available under a
The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. It. https://doi.org/10.1101/630236doi: bioRxiv preprint 
29 
 
New Genomic Insights Using the GBT Random Insertion Mutagen 1 
The ready ease of these mRFP-based protein traps for basic expression analyses demonstrates how much 2 
we do not know about our overall proteome and the codex that is our genome. Nearly forty percent and 3 
five of six of the cloned genes show no expression at 2dpf and 4dpf, respectively, in ZFIN. At the 4 
subcellular level, such protein traps in conjunction with new microscopy techniques represent just 5 
another method for cellular and mechanistic analyses in an in vivo cellular context. Although these were 6 
made using random insertional approaches, new targeted integration tools using gene editing such as 7 
GeneWeld(Wierson et al., 2018) should readily empower labs to build their custom GBT lines in the 8 
future for genes not in this collection. Together, this initial 1100+ GBT collection is a new contribution 9 
to the use of the zebrafish to annotate the vertebrate genome.  10 
  11 
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Figure legends 1 
Table 1 Comparison availability of expression data  2 
Table 2 Protein classification 3 
Table 3 Disease-causing human orthologues 4 
Table 4 Potential novel human disease models  5 
Table 5 Novel transcripts    6 
Figure 1 Schematic of the RP2 and RP8 gene-break transposon system with all three reading 7 
frames of AUG-less mRFP reporter 8 
A. Schematic of the RP2 system fused with 3 reading frames of AUG-less mRFP reporter (RP2.1, RP2.2 9 
and RP2.3). B. Schematic of the RP2 system fused with 3 reading frames of AUG-less mRFP reporter 10 
(RP8.1, RP8.2 and RP8.3). ITR, inverted terminal repeat; SA, loxP; Cre recombinase recognition 11 
sequence,  splice acceptor; *mRFP’ AUG-less mRFP sequence; poly (A)+, polyadenylation signal; red 12 
octagon, extra transcriptional terminator and putative border element; β-act, carp beta-actin enhancer, 13 
SD, splice donor; E, enhancer; P, promoter; and WT, wild type. 14 
Figure 2 Novel protein expression 15 
Representative novel expression data of trapped proteins fused to the mRFP reporter in this GBT 16 
collection. A. unkl localized in olfactory pit, cerebrum and spinal cord at 4dpf. B. nusap1 localized in 17 
retina and the top layer of both forebrain and midbrain at 4 dpf. C. zgc:194659 strongly expressed in the 18 
brain and spinal cord at 4 dpf. D. marcksl1a expressed in the lens, skin and notochord at 2 dpf. E. pipp2a 19 
specifically localized to otoliths at 2 dpf. F. ahnak specifically expressed in skin at 4 dpf. G. dph1 20 
ubiquitously expressed showing granulized pattern in somites at 4 dpf. H. nfatc3a expressed in skeletal 21 
muscle and skin at 4 dpf . I. pard3bb localized to the pronephros and gut at 4 dpf. White arrowhead 22 
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shows an artificial expression in lens driven by the promoter of 3’ exon trap of RP8.1.  J. 1 
LOC100537272 expressed in circulatory cells in the blood stream at 4 dpf.            2 
Figure 3 High knockdown efficiency of RP2.1 compared with other previous gene-trap systems 3 
Black dots of bar graphs shows percentage of remaining endogenous transcripts in homozygous larvae 4 
with mean and 95% confidence interval indicated by individual lines. The data of previous protein trap 5 
systems were also converted from the data in the original articles, R14-R15, our initial R-series protein 6 
trap vectors (n= 6),(Clark, Balciunas, et al., 2011) ; FlipTrap, FlipTrap vectors (n= 6), (Trinh le et al., 7 
2011); FT1, FT1 vector (n=4),(T. T. Ni et al., 2012); RP2.1 (n=26), (Clark, Balciunas, et al., 2011; Ding 8 
et al., 2013; El-Rass et al., 2017; Westcot et al., 2015) and unpublished data),  9 
Figure 4 Summary of protein classes categorized the trapped proteins using PANTHER algorism 10 
77 trapped genes were successfully categorized at least one of 21 protein classes by using PANTHER 11 
gene ontology algorism. The details of the trapped genes classified in each protein class are listed in 12 
Table 2.    13 
Figure 5 Disease-causing human orthologues of the trapped genes involved in human genetic 14 
disorders in multi-organ systems. 15 
Supplemental Table 1 Generation of 11 hundred independent lines by all three reading frames of 16 
mRFP reporter in both RP2 and RP8 cassettes. 17 
Supplemental Table 2 Disease-causing human orthologues of the trapped protein  18 
Supplemental Figure 1 Representative expression patterns of mRFP fusion protein by RP2 and 19 
RP8 integration 20 
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2 dpf 4 dpf
zfishbook and ZFIN 45 10
zfishbook 75 155
ZFIN 20 2
Not available 36 9
The number of genes
Expression data exist
Table 1 
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Protein Class Mapped ID Gene Symbol Gene Name
nucleic acid binding (PC00171)
ZDB-GENE-040426-893 gar1 H/ACA ribonucleoprotein complex subunit 1
ZDB-GENE-060503-160 adarb2 Adenosine deaminase, RNA-specific, B2 (non-functional) (Fragment)
ZDB-GENE-000405-1 pbx1a Pbx1a homeodomain protein
ZDB-GENE-060130-4 zfpm2a Zinc finger protein, FOG family member 2a
ZDB-GENE-050417-327 eef1a1b Elongation factor 1-alpha
ZDB-GENE-081104-328 enox1 Ecto-NOX disulfide-thiol exchanger 1
ZDB-GENE-050419-169 ddb2 DNA damage-binding protein 2
ZDB-GENE-980526-306 msxc Homeobox protein MSH-C
ZDB-GENE-020529-1 tbx15 T-box 15
ZDB-GENE-070314-2 rxraa Retinoic acid receptor RXR-alpha-A
ZDB-GENE-030131-6117 dido1 Death inducer-obliterator 1
ZDB-GENE-050913-153 barhl2 BarH-class homeodomain transcription factor
ZDB-GENE-040426-1272 ddb1 Damage-specific DNA-binding protein 1
ZDB-GENE-980526-499 stat1a Signal transducer and activator of transcription
ZDB-GENE-050517-31 abcf1 ATP-binding cassette, sub-family F (GCN20), member 1
ZDB-GENE-080403-11 kat2a Histone acetyltransferase KAT2A
ZDB-GENE-030131-4505 dhx37 DEAH (Asp-Glu-Ala-His) box polypeptide 37
ZDB-GENE-060512-241 foxl2a Forkhead box L2
ZDB-GENE-041014-310 mcm9 DNA helicase MCM9
transcription factor (PC00218)
ZDB-GENE-050419-261 wtip Wilms tumor protein 1-interacting protein homolog
ZDB-GENE-050913-139 znf1015 Zinc finger protein 1015
ZDB-GENE-000405-1 pbx1a Pbx1a homeodomain protein
ZDB-GENE-060130-4 zfpm2a Zinc finger protein, FOG family member 2a
ZDB-GENE-000710-4 zic2a ZIC family member 2 (Odd-paired homolog, Drosophila), A
ZDB-GENE-061207-62 bcl11ba B cell CLL/lymphoma 11Ba
ZDB-GENE-050419-146 bhlhe41 BHLH protein DEC2
ZDB-GENE-030131-6789 taf6l TAF6-like RNA polymerase II, p300/CBP-associated factor (PCAF)-associated factor
ZDB-GENE-980526-306 msxc Homeobox protein MSH-C
ZDB-GENE-020529-1 tbx15 T-box 15
ZDB-GENE-070314-2 rxraa Retinoic acid receptor RXR-alpha-A
ZDB-GENE-030131-6117 dido1 Death inducer-obliterator 1
ZDB-GENE-050913-153 barhl2 BarH-class homeodomain transcription factor
ZDB-GENE-980526-499 stat1a Signal transducer and activator of transcription
ZDB-GENE-060130-108 casz1 Castor zinc finger 1
ZDB-GENE-060512-241 foxl2a Forkhead box L2
ZDB-GENE-041111-41 nfatc3a Nuclear factor of-activated T cells 3a
hydrolase (PC00121)
ZDB-GENE-040611-3 nrp2b Neuropilin
ZDB-GENE-060503-160 adarb2 Adenosine deaminase, RNA-specific, B2 (non-functional) (Fragment)
ZDB-GENE-070112-1812 pnpla7a Patatin-like phospholipase domain-containing 7a
ZDB-GENE-050417-327 eef1a1b Elongation factor 1-alpha
ZDB-GENE-040718-393 ada Adenosine deaminase
ZDB-GENE-140703-2 plpp2a Phospholipid phosphatase 2a
ZDB-GENE-080818-1 ca16b Carbonic anhydrase XVI b
ZDB-GENE-050517-31 abcf1 ATP-binding cassette, sub-family F (GCN20), member 1
ZDB-GENE-060503-530 ptprf Receptor-type tyrosine-protein phosphatase F
ZDB-GENE-070117-757 parga Poly(ADP-ribose) glycohydrolase
ENSDARG00000010758 capn12 Calpain 12
ZDB-GENE-041014-310 mcm9 DNA helicase MCM9
receptor (PC00197)
ZDB-GENE-050419-65 v2rl1 Vomeronasal 2 receptor, l1
ZDB-GENE-060503-5 gabbr1b Gamma-aminobutyric acid (GABA) B receptor, 1b
ZDB-GENE-070314-2 rxraa Retinoic acid receptor RXR-alpha-A
ZDB-GENE-030131-2427 col7a1 Collagen, type VII, alpha 1
ZDB-GENE-030909-10 itgb1b Integrin beta
ZDB-GENE-080818-1 ca16b Carbonic anhydrase XVI b
ZDB-GENE-091027-1 tgfbr1b Serine/threonine-protein kinase receptor
ZDB-GENE-070905-3 crfb4 Cytokine receptor family member b4
transferase (PC00220)
ZDB-GENE-030131-2049 mat2aa S-adenosylmethionine synthase
ZDB-GENE-040426-1516 mboat7 Lysophospholipid acyltransferase 7
ZDB-GENE-121129-1 csgalnact1a Hexosyltransferase
ZDB-GENE-060616-238 mgat5 Mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase
ZDB-GENE-080403-11 kat2a Histone acetyltransferase KAT2A
ZDB-GENE-030131-825 csnk1da Casein kinase I isoform delta-A
ZDB-GENE-091027-1 tgfbr1b Serine/threonine-protein kinase receptor
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transporter (PC00227)
ZDB-GENE-130103-1 cacna1ha Voltage-dependent T-type calcium channel subunit alpha
ZDB-GENE-050419-65 v2rl1 Vomeronasal 2 receptor, l1
ZDB-GENE-070705-417 ryr1b Ryanodine receptor 1b (skeletal)
ZDB-GENE-001127-2 atp1b2a Sodium/potassium-transporting ATPase subunit beta
ZDB-GENE-050517-31 abcf1 ATP-binding cassette, sub-family F (GCN20), member 1
ZDB-GENE-070718-4 oca2 Oculocutaneous albinism II
enzyme modulator (PC00095) 
ZDB-GENE-060503-160 adarb2 Adenosine deaminase, RNA-specific, B2 (non-functional) (Fragment)
ZDB-GENE-050417-327 eef1a1b Elongation factor 1-alpha
ZDB-GENE-030131-9805 ppp1r13ba Protein phosphatase 1, regulatory subunit 13Ba
ZDB-GENE-110411-39 si:dkey-222l13.1 Si:dkey-222l13.1
ZDB-GENE-040426-1131 phactr4b Phosphatase and actin regulator 4B
membrane traffic protein (PC00150)
ZDB-GENE-030131-5290 napab N-ethylmaleimide sensitive fusion protein attachment protein alpha
ZDB-GENE-050522-134 syt5b Synaptotagmin Vb
ZDB-GENE-040718-281 vapal VAMP (vesicle-associated membrane protein)-associated protein A,-like
ZDB-GENE-050522-235 sncgb Synuclein, gamma b (breast cancer-specific protein 1)
ZDB-GENE-110411-39 si:dkey-222l13.1 Si:dkey-222l13.1
signaling molecule (PC00207)
ZDB-GENE-091204-186 sh3kbp1 SH3-domain kinase-binding protein 1
ZDB-GENE-080225-17 arhgef25b Rho guanine nucleotide exchange factor (GEF) 25b
ZDB-GENE-070615-10 nrg2a Neuregulin 2a
ZDB-GENE-041114-101 fgf13a Fibroblast growth factor
ZDB-GENE-040426-1793 fgf13b Fibroblast growth factor
cytoskeletal protein (PC00085) 
ZDB-GENE-070112-1512 wasf3b WAS protein family, member 3b
ZDB-GENE-080215-23 map7d1b MAP7 domain-containing 1b
ZDB-GENE-060503-22 map7d1a MAP7 domain-containing 1a
ZDB-GENE-000626-1 tnnt2a Troponin T type 2a (cardiac)
defense/immunity protein (PC00090)
ZDB-GENE-060503-160 adarb2 Adenosine deaminase, RNA-specific, B2 (non-functional) (Fragment)
ZDB-GENE-040426-2136 b2ml Beta-2-microglobulin
ZDB-GENE-070905-3 crfb4 Cytokine receptor family member b4
chaperone (PC00072)
ZDB-GENE-040426-876 cct8 Chaperonin-containing TCP1, subunit 8 (theta)
ZDB-GENE-050522-235 sncgb Synuclein, gamma b (breast cancer-specific protein 1)
ligase (PC00142)
ZDB-GENE-090313-285 zmiz2 Zinc finger, MIZ-type-containing 2
ZDB-GENE-070912-399 si:dkey-181m9.8 Si:dkey-181m9.8
structural protein (PC00211)
ZDB-GENE-030710-8 gpm6ab Glycoprotein M6Ab (Fragment)
ZDB-GENE-030710-9 gpm6ba DMgamma1
transmembrane receptor regulatory/adaptor protein (PC00226)
ZDB-GENE-081030-10 cntn3a.1 Contactin 3a, tandem duplicate 1
ZDB-GENE-010724-8 dlg1 Disks large homolog 1
cell adhesion molecule (PC00069) 
ZDB-GENE-030909-10 itgb1b Integrin beta
extracellular matrix protein (PC00102) 
ZDB-GENE-101112-3 megf6b Multiple EGF-like-domains 6b
lyase (PC00144)
ZDB-GENE-141030-2 npr2 Guanylate cyclase
oxidoreductase (PC00176) 
ZDB-GENE-081104-328 enox1 Ecto-NOX disulfide-thiol exchanger 1
transfer/carrier protein (PC00219)
ZDB-GENE-060628-2 xpo7 Exportin 7
calcium-binding protein (PC00060)
ENSDARG00000010758 capn12 Calpain 12
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Line
ZF NCBI 
gene ID ZF gene symbol
Human Orthologue 
NCBI Gene ID
Human Orthologue 
Gene symbol
GBT0001 559053 casz1 54897 CASZ1
GBT0002 563408 sorbs2b 8470 SORBS2
GBT0005 570216 itgb1b 3688 ITGB1
GBT0007 794348 nrde2 55051 NRDE2
GBT0010 30461 cdh11 1009 CDH11
GBT0016 58138 pbx1a 5087 PBX1
GBT0019 565629 kcnk10b 54207 KCNK10
GBT0020 569437 cntn3a.1 5067 CNTN3
GBT0021 571891 cntnap5b 129684 CNTNAP5
GBT0025 553277 dido1 11083 DIDO1
GBT0028 101882228 CABZ01057928.1 1729 DIAPH1
GBT0031 58071 tnnt2a 7139 TNNT2
GBT0033 100003333 lrch4 4034 LRCH4
GBT0034 567642 si:dkey-181m9.8
GBT0035 559134 parga 8505 PARG
GBT0038 541513 srpx 8406 SRPX
GBT0039 559579 gabbr1,2 2550 GABBR1
GBT0040 58049 hoxa3a 3201 HOXA4
GBT0043 323266 cd99l2 83692 CD99L2
GBT0046 64270 epha4b 2043 EPHA4
GBT0060 797527 crfb4 3588 IL10RB
GBT0067 559614 myom3 127294 MYOM3
GBT0070 555610 mcm9 254394 MCM9
GBT0073 406467 abcf1 23 ABCF1
GBT0077 406467 abcf1 23 ABCF1
GBT0078 558006 grip1 23426 GRIP1
GBT0082 394037 cct8 10694 CCT8
GBT0091 100002220 enox1 55068 ENOX1
GBT0094 403003 fgf13b 2258 FGF13
GBT0096 394094 sh3glb2b 56904 SH3GLB2
GBT0101 553277 dido1 11083 DIDO1
GBT0103 100002190 cyth3a 9265 CYTH3
GBT0111 569081 rerea 473 RERE
GBT0113 569437 cntn3a.1 5067 CNTN3
GBT0125 100333685 cd302 9936 CD302
GBT0126 405902 nrp2b 8828 NRP2
GBT0131 100004133 ddb2 1643 DDB2
GBT0133 58077 zic2a 7546 ZIC2
GBT0135 563771 bhlhe41 79365 BHLHE41
GBT0137 100004503 eef1a1b 1915 EEF1A1
GBT0141 368225 gpm6ba 2824 GPM6B
GBT0142 100004850 aatka 9625 AATK
GBT0143 566046 wtip 126374 WTIP
GBT0144 565405 unkl 64718 UNKL
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GBT0145 560542 epn2 22905 EPN2
GBT0151 567446 nusap1 51203 NUSAP1
GBT0154 449761 si:ch211-163l21.8 57535 KIAA1324
GBT0156 563428 fras1 80144 FRAS1
GBT0157 724006 mgat5 4249 MGAT5
GBT0166 64269 atp1b2a 482 ATP1B2
GBT0168 492758 fgf13a 2258 FGF13
GBT0170 378997 glcci1a 113263 GLCCI1
GBT0172 337397 tmem30aa 55754 TMEM30A
GBT0175 569561 arhgef25b 115557 ARHGEF25
GBT0178 436919 ada 100 ADA
GBT0181 30155 tenm3 55714 TENM3
GBT0186 170581 cacna1c 775 CACNA1C
GBT0187 100007836 si:dkey-253d23.3
GBT0189 562459 znf414 84330 ZNF414
GBT0190 100001699 barhl2 343472 BARHL2
GBT0195 562459 znf414 84330 ZNF414
GBT0196 559276 ahnak 79026 AHNAK
GBT0200 541428 znrd1 30834 ZNRD1
GBT0201 556341 mhc1zca 3140 MR1
GBT0202 569081 rerea 473 RERE
GBT0203 678534 ntm 150084 IGSF5
GBT0204 492787 cadm4 199731 CADM4
GBT0205 100151756 fam117ab 81558 FAM117A
GBT0208 641575 actn2b 88 ACTN2
GBT0209 550559 dph1 1801 DPH1
GBT0230 797651 jam3a 83700 JAM3
GBT0231 266983 neo1a 4756 NEO1
GBT0232 553567 syt5b 6861 SYT5
GBT0235 557195 lrpprc 10128 LRPPRC
GBT0237 100006951 nrg2a 9542 NRG2
GBT0238 792928 tgfbr1b 7046 TGFBR1
GBT0239 796270 map7d1b 55700 MAP7D1
GBT0240 100093707 bcl11ba 64919 BCL11B
GBT0241 561900 fip1l1a 81608 FIP1L1
GBT0242 554131 tex261 113419 TEX261
GBT0243 563577 ppp1r13ba 23368 PPP1R13B
GBT0245 30526 msx3
GBT0249 791742 b2ml 567 B2M
GBT0250 386769 ptprma 5797 PTPRM
GBT0251 692279 foxl2a 668 FOXL2
GBT0255 114441 ncam2 4685 NCAM2
GBT0256 550554 ppp3cb 5530 PPP3CA
GBT0261 799247 capn12 147968 CAPN12
GBT0263 559150 hmcn1 83872 HMCN1
GBT0268 100534737 ano5a 203859 ANO5
GBT0270 568996 zfpm2a 23414 ZFPM2
Table 3_Human orthologues of GBT confirmed genes updated Apr8-2019.xlsx
.CC-BY 4.0 International licenseis made available under a
The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. It. https://doi.org/10.1101/630236doi: bioRxiv preprint 
GBT0271 565172 map7d1a 55700 MAP7D1
GBT0275 554270 col4a4 1286 COL4A4
GBT0281 797715 ogdhb 4967 OGDH
GBT0283 793623 sh3kbp1 30011 SH3KBP1
GBT0286 797252 emid1 129080 EMID1
GBT0292 541428 znrd1 30834 ZNRD1
GBT0298 100007373 zgc:194659
GBT0312 799867 ptprfb 5792 PTPRF
GBT0313 565460 csmd2 114784 CSMD2
GBT0316 324381 fkbp10b 60681 FKBP10
GBT0319 791987 ino80c 125476 INO80C
GBT0321 791987 ino80c 125476 INO80C
GBT0322 101886266 si:ch211-160j14.3 91522 COL23A1
GBT0323 558149 adarb2 105 ADARB2
GBT0325 557764 megf6b 1953 MEGF6
GBT0329 793671 csgalnact1a 55790 CSGALNACT1
GBT0340 561772 nfatc3a 4775 NFATC3
GBT0346 553730 lrmda 83938 LRMDA
GBT0348 570245 ryr1b 6261 RYR1
GBT0357 569183 ca16b 5793 PTPRG
GBT0364 323329 mat2aa 4144 MAT2A
GBT0365 553679 sncgb 6623 SNCG
GBT0369 407734 gpm6ab 2823 GPM6A
GBT0380 795234 znf1140
GBT0383 554230 kdr 3791 KDR
GBT0389 767723 mosmob 730094 MOSMO
GBT0396 562557 smg9 56006 SMG9
GBT0397 393643 phactr4b 65979 PHACTR4
GBT0398 791173 pnpla7a 375775 PNPLA7
GBT0399 571887 kirrel3a 84623 KIRREL3
GBT0401 560003 ERC1 23085 ERC1
GBT0402 566484 scaf11 9169 SCAF11
GBT0404 564731 CABZ01045212.1 ENSGGOG00000007420
GBT0409 100331745 npr2 4882 NPR2
GBT0410 436819 vapal 9218 VAPA
GBT0411 393275 dnajb6b 10049 DNAJB6
GBT0412 407710 xpo7 23039 XPO7
GBT0415 570029 arrdc1b 92714 ARRDC1
GBT0416 322795 csrnp1b 64651 CSRNP1
GBT0419 555578 rxraa 6256 RXRA
GBT0422 245700 insrb 3643 INSR
GBT0424 566039 v2rl1
GBT0425 550455 mrps18b 28973 MRPS18B
GBT0433 393599 ddb1 1642 DDB1
GBT0434 393950 gar1 54433 GAR1
GBT0435 558326 nrxn2a 9379 NRXN2
GBT0437 445226 casq1a 844 CASQ1
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GBT0503 30768 stat1a 6772 STAT1
GBT0505 572369 kirrel3b 84623 KIRREL3
GBT0510 553343 si:ch211-266g18.10 10345 TRDN
GBT0511 567419 oca2 4948 OCA2
GBT0513 65239 map2k6 5608 MAP2K6
GBT0520 553367 gpc1a 2817 GPC1
GBT0522 30708 fabp2 2169 FABP2
GBT0523 406407 marcksl1a 65108 MARCKSL1
GBT0525 100333948 mapk8ip1b 9479 MAPK8IP1
GBT0527 386629 tob1a 10140 TOB1
GBT0528 323269 zbtb16a 7704 ZBTB16
GBT0534 327082 napab 8775 NAPA
GBT0545 563632 wasf3b 10810 WASF3
GBT0552 562615 znf1015 163033 ZNF579
GBT0554 492500 gsto2 119391 GSTO2
GBT0570 30154 gli2a 2736 GLI2
GBT0572 568184 lrp2a 4036 LRP2
GBT0585 30256 kita 3815 KIT
GBT0591 100009635 dhx37 57647 DHX37
GBT0593 393716 skp1 6500 SKP1
GBT0599 768182 mcu 90550 MCU
GBT0700 558875 ttc23 64927 TTC23
GBT0710 564112 magi2a 9863 MAGI2
GBT0717 557363 taf6l 10629 TAF6L
GBT0722 569986 dip2cb 22982 DIP2C
GBT0726 100003611 radx 55086 RADX
GBT0734 100149334 si:dkey-15h8.15
GBT0750 557081 col7a1 1294 COL7A1
GBT0757 555517 kat2a 2648 KAT2A
GBT0760 110437953 adgrl2b.1 23266 ADGRL2
GBT0776 796370 edar 10913 EDAR
GBT0785 393509 mboat7 79143 MBOAT7
GBT0795 562459 znf414 84330 ZNF414
GBT0906 393638 timm50 92609 TIMM50
GBT0926 790941 dele1 9812 DELE1
GBT0936 541552 eya4 2070 EYA4
GBT0941 100333571 zmiz2 83637 ZMIZ2
GBT0951 393521 macrod2 140733 MACROD2
GBT0959 562529 flna 2316 FLNA
GBT0966 563806 plpp2a 8612 PLPP2
GBT0972 114446 dlg1 1739 DLG1
GBT0978 568996 zfpm2a 23414 ZFPM2
GBT0980 559150 hmcn1 83872 HMCN1
GBT0993 557073 cdip1 29965 CDIP1
GBT1023 322106 csnk1da 1453 CSNK1D
GBT1027 557315 kirrel3l 84063 KIRREL2
GBT1033 555701 rreb1b 6239 RREB1
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GBT1042 562146 pard3bb 117583 PARD3B
GBT1093 100126126 ryr2a 6262 RYR2
GBT1105 246222 tbx15 6913 TBX15
GBT1129 560875 cacna1ha 8912 CACNA1H
GBT1248 100148041 tnk2a 10188 TNK2
GBT1259 100537272 LOC100537272
GBT1278 735249 selenos 55829 SELENOS
GBT1300 386856 pdgfra 5156 PDGFRA
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GBT Tagged Gene Human Orthologue Human Disease
Disease Models 
(Number of models)
Reference
(PMID)
GBT0016 pbx1a PBX1
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH ORWITHOUT HEARING LOSS 
ABNORMAL EARS OR DEVELOPMENTAL DELAY mouse (1) 12591246
GBT0031 tnnt2a TNNT2 CARDIOMYOPATHY DILATED 1D mouse (5)
18606313, 
27936050, 
17556660, 
18349139
GBT0031 tnnt2a TNNT2 CARDIOMYOPATHY FAMILIAL HYPERTROPHIC 2 mouse (9)
16326803, 
9788962, 
11171784, 
18349139, 
10449439, 
9637714, 
23532597
GBT0078 grip1 GRIP1 FRASER SYNDROME 3 mouse (2)
14730302, 
16880404
GBT0131 ddb2 DDB2 XERODERMA PIGMENTOSUM COMPLEMENTATION GROUP E mouse (4)
14769931, 
15558025
GBT0133 zic2a ZIC2 HOLOPROSENCEPHALY 5 mouse (3)
27466203, 
18617531, 
10677508
GBT0135 bhlhe41 BHLHE41 SHORT SLEEPER mouse (1) 19679812
GBT0156 fras1 FRAS1 FRASER SYNDROME 1 mouse (5)
12766769, 
12766770, 
24143185, 
15623520, 
15838507
GBT0178 ada ADA
SEVERE COMBINED IMMUNODEFICIENCY AUTOSOMAL RECESSIVE TCELL-NEGATIVE B CELL-NEGATIVE NK CELL-
NEGATIVE DUE TO ADENOSINEDEAMINASE DEFICIENCY mouse (1) 9478961
GBT0186 cacna1c CACNA1C TIMOTHY SYNDROME mouse (1) 21878566
GBT0240 bcl11ba BCL11B IMMUNODEFICIENCY 49 zebrafish (1)
GBT0251 foxl2a FOXL2 Blepharophimosis ptosis and epicanthus inversus mouse (3)
15056605, 
14736745, 
24565867
GBT0268 ano5a ANO5 MUSCULAR DYSTROPHY LIMB-GIRDLE AUTOSOMAL RECESSIVE 12 mouse (1) 26911675
GBT0270 zfpm2a ZFPM2 Tetralogy of Fallot mouse (1)
10892744, 
12223418
GBT0270 zfpm2a ZFPM2 DIAPHRAGMATIC HERNIA 3 mouse (1) 16103912
GBT0275 col4a4 COL4A4 ALPORT SYNDROME AUTOSOMAL RECESSIVE mouse (4)
21196518, 
24522496
GBT0348 ryr1b RYR1 CENTRAL CORE DISEASE OF MUSCLE mouse (3)
25564733, 
19959667, 
7515481
GBT0396 smg9 SMG9 HEART AND BRAIN MALFORMATION SYNDROME mouse (1) 27018474
GBT0409 npr2 NPR2 Acromesomelic dysplasia Maroteaux type mouse (2)
23065701, 
17728275
GBT0411 dnajb6b DNAJB6 autosomal dominant limb-girdle muscular dystrophy type 1 zebrafish (1-NOT), mouse (1) 26362252
GBT0422 insrb INSR DONOHUE SYNDROME mouse (2-NOT)
GBT0511 oca2 OCA2 ALBINISM OCULOCUTANEOUS TYPE II rabbit (1)
Magnussen, 
K. (1952).
GBT0572 lrp2a LRP2 DONNAI-BARROW SYNDROME mouse (1) 20653565
GBT0585 kita KIT MASTOCYTOSIS CUTANEOUS mouse (5)
24788138, 
21148330
GBT0585 kita KIT Piebald trait mouse (1) 20095975
GBT0585 kita KIT Gastrointestinal stromal tumor mouse (5)
16061643, 
22652566, 
18098338, 
12754375
GBT0710 magi2a MAGI2 NEPHROTIC SYNDROME TYPE 15 mouse (1) 25271328
GBT0750 col7a1 COL7A1 recessive dystrophic epidermolysis bullosa mouse (4)
18382769, 
19893033, 
10523500
GBT0776 edar EDAR hypohidrotic ectodermal dysplasia mouse (1)
10431242, 
17148670, 
9799835
GBT0776 edar EDAR HAIR MORPHOLOGY 1 mouse (1) 18561327
GBT0785 mboat7 MBOAT7 MENTAL RETARDATION AUTOSOMAL RECESSIVE 57 mouse (1) 23097495
GBT0959 flna FLNA Periventricular nodular heterotopia 1 mouse (1) 16825286
GBT1023 csnk1da CSNK1D ADVANCED SLEEP PHASE SYNDROME FAMILIAL 2 mouse (2) 15800623
GBT1093 ryr2a RYR2
Ventricular tachycardia catecholaminergic polymorphic 1 with or without atrial dysfunction and/or dilated 
cardiomyopathy mouse (10)
27482086, 
25775566, 
26121139, 
24755079, 
23152493, 
22828895, 
20224043, 
18419777, 
16873551, 
15890976
GBT1093 ryr2a RYR2 ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA FAMILIAL 2 mouse (1) 16873551
GBT1105 tbx15 TBX15 COUSIN SYNDROME mouse (1) 19068278
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Line Vector Genome location Genome version
GBT0115 RP2 chr8:12923125-12923133 ZV9
GBT0129 RP2 chr12:45451589-45451597 ZV9
GBT0148 RP2 chr16:55188302-55188310 ZV9
GBT0264 RP2 chr5:49960612-49960620 ZV9
GBT0506 RP2 chr18:46186350-46186358 ZV9
GBT0573 RP2 chr6:33630487-33630495 GRCz10
GBT0586 RP2 chr13:9112806-9112814 GRCz10
GBT0702 RP2 chr13:9112806-9112814 GRCz10
GBT0724 RP8 chr7:7633071-7633079 GRCz10
GBT0994 RP2 chr3:39627361-39627369 GRCz10
GBT1024 RP2 chr25:5175242-5175250 GRCz10
GBT1071 RP8 chr9:21818261-21818269 GRCz10
GBT1100 RP2 chr5:25509243-25509251 GRCz10
GBT1116 RP2 chr14:14724098-14724106 GRCz10
GBT1168 RP2 chr5:39664405-39664412 GRCz10
Table 5 
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